Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionEverett Harris & Co /ca/
Latest Disclosed Ownership7,723 shares
Latest Disclosed Value $ 468,400
Everett Harris & Co /ca/ reports 28.58% decrease in ownership of BRM / Bristol-Myers Squibb Company

On May 8, 2026 - Everett Harris & Co /ca/ filed a 13F-HR form disclosing ownership of 7,723 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $404,840 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 10,813 shares of Bristol-Myers Squibb Company. This represents a change in shares of -28.58% during the quarter. The current value of the position is $366,302 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F Bristol Myers Squibb COM 110122108 7,723 -3,090 -28.58 468 -19.73 0.0060
2026-02-11 2025-12-31 13F Bristol Myers Squibb COM 110122108 10,813 -3,000 -21.72 583 -6.27 0.0071
2025-11-03 2025-09-30 13F Bristol Myers Squibb COM 110122108 13,813 0 0.00 623 -2.66 0.0077
2025-08-08 2025-06-30 13F Bristol Myers Squibb COM 110122108 13,813 1,143 9.02 639 -17.23 0.0082
2025-05-12 2025-03-31 13F Bristol Myers Squibb COM 110122108 12,670 -131 -1.02 773 6.63 0.0099
2025-01-24 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 12,801 31 0.24 724 9.70 0.0091
2024-10-18 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 12,770 0 0.00 661 24.53 0.0082
2024-08-02 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 12,770 0 0.00 530 -23.41 0.0068
2024-04-19 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 12,770 -445 -3.37 693 2.06 0.0092
2024-01-18 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 13,215 -3,367 -20.31 678 -29.52 0.0097
2023-10-24 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 16,582 -324 -1.92 962 -11.01 0.0150
2023-07-27 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 16,906 -513 -2.95 1,081 -10.44 0.0164
2023-04-25 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 17,419 0 0.00 1,207 -3.67 0.0196
2023-01-20 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 17,419 0 0.00 1,253 1.21 0.0215
2022-10-21 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,419 0 0.00 1,238 -7.68 0.0228
2022-07-22 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,419 854 5.16 1,341 10.83 0.0232
2022-04-22 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 16,565 395 2.44 1,210 20.04 0.0172
2022-02-02 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 16,170 -450 -2.71 1,008 2.54 0.0140
2021-11-03 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 16,620 450 2.78 983 -8.98 0.0155
2021-07-29 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 16,170 0 0.00 1,080 5.78 0.0173
2021-05-13 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 16,170 0 0.00 1,021 1.79 0.0177
2021-02-04 2020-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 16,170 -300 -1.82 1,003 1.01 0.0177
2020-11-03 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 16,470 0 0.00 993 2.58 0.0194
2020-07-29 2020-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 16,470 200 1.23 968 6.73 0.0214
2020-04-29 2020-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 16,270 2,900 21.69 907 5.71 0.0234
2020-01-27 2019-12-31 13F Bristol Myers Squibb COM 110122108 13,370 13,370 858 0.0194
2019-11-06 2019-09-30 13F Bristol Myers Squibb COM 110122108 0 -8,450 -100.00 0 -100.00
2019-08-13 2019-06-30 13F Bristol Myers Squibb COM 110122108 8,450 -948 -10.09 383 -14.51 0.0096
2019-05-13 2019-03-31 13F Bristol Myers Squibb COM 110122108 9,398 0 0.00 448 -8.38 0.0116
2019-02-13 2018-12-31 13F Bristol Myers Squibb COM 110122108 9,398 0 0.00 489 -16.12 0.0139
2018-11-14 2018-09-30 13F Bristol Myers Squibb COM 110122108 9,398 -600 -6.00 583 5.42 0.0146
2018-07-27 2018-06-30 13F Bristol Myers Squibb COM 110122108 9,998 600 6.38 553 -6.90 0.0151
2018-04-20 2018-03-31 13F Bristol Myers Squibb COM 110122108 9,398 0 0.00 594 3.13 0.0165
2018-02-01 2017-12-31 13F/A-1 Bristol Myers Squibb COM 110122108 9,398 0 0.00 576 -3.84 0.0161
2018-01-30 2017-12-31 13F Bristol Myers Squibb COM 110122108 9,398 0 599
2017-10-11 2017-09-30 13F Bristol Myers Squibb COM 110122108 9,398 0 0.00 599 14.31 0.0180
2017-08-03 2017-06-30 13F Bristol Myers Squibb COM 110122108 9,398 70 0.75 524 3.35 0.0162
2017-04-26 2017-03-31 13F Bristol Myers Squibb COM 110122108 9,328 800 9.38 507 1.81 0.0166
2017-02-07 2016-12-31 13F Bristol Myers Squibb COM 110122108 8,528 0 0.00 498 8.26 0.0175
2016-10-26 2016-09-30 13F Bristol Myers Squibb COM 110122108 8,528 0 0.00 460 -26.63 0.0163
2016-08-03 2016-06-30 13F Bristol Myers Squibb COM 110122108 8,528 0 0.00 627 15.05 0.0224
2016-04-26 2016-03-31 13F Bristol Myers Squibb COM 110122108 8,528 0 0.00 545 -7.16 0.0196
2016-02-09 2015-12-31 13F Bristol Myers Squibb COM 110122108 8,528 0 0.00 587 16.24 0.0205
2015-11-12 2015-09-30 13F Bristol Myers Squibb COM 110122108 8,528 0 0.00 505 -10.93 0.0185
2015-08-12 2015-06-30 13F Bristol Myers Squibb COM 110122108 8,528 0 0.00 567 3.09 0.0199
2015-05-12 2015-03-31 13F Bristol Myers Squibb COM 110122108 8,528 0 0.00 550 9.34 0.0189
2015-02-11 2014-12-31 13F Bristol Myers Squibb COM 110122108 8,528 0 0.00 503 15.37 0.0172
2014-11-06 2014-09-30 13F Bristol Myers Squibb COM 110122108 8,528 0 0.00 436 5.31 0.0157
2014-08-05 2014-06-30 13F Bristol Myers Squibb COM 110122108 8,528 300 3.65 414 -3.04 0.0153
2014-05-19 2014-03-31 13F Bristol Myers Squibb COM 110122108 8,228 0 0.00 427 -2.29 0.0159
2014-02-13 2013-12-31 13F Bristol Myers Squibb COM 110122108 8,228 0 0.00 437 14.70 0.0163
2013-11-01 2013-09-30 13F Bristol Myers Squibb COM 110122108 8,228 -500 -5.73 381 -2.31 0.0155
2013-07-24 2013-06-30 13F Bristol Myers Squibb COM 110122108 8,728 8,728 390 0.0163
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.